Key Takeaways The FDA hasnt approved any GLP-1 patches to treat weight loss or diabetes
If you navigate the daily realities of sensitive airways, you likely scrutinize every new addition to your wellness routine
Berkowitz SA, Seligman HK, Mozaffarian D
While Asia is capturing high-growth tailwinds, OECD markets remain steady but more regulated, requiring adaptive commercialization across channels, especially where Rx-OTC hybrid categories are evolving
The key point: BPC-157 injections may be a better fit when the goal is deeper tissue or injury-related support, but they should only be used under medical guidance
FDA approves new drug treatment for Chronic Weight Management, first since 2014